Skip to main content Skip to secondary navigation


Main content start

2022    2021    2020     2019     2018     2017       


Hutton DW, Toy M, Salomon JA, Conners EE, Nelson NP, Harris AM, So S. Cost-effectiveness of hepatitis B testing and vaccination of adults seeking care for sexually transmitted infections. Sex Transm Dis. 2022;49(7):517-525. doi:10.1097/OLQ.0000000000001632

Kim S, Cohen T, Horsburgh CR, Miller JW, Hill AN, Marks SM, Li R, Kammerer JS, Salomon JA, Menzies NA. Trends, mechanisms, and racial/ethnic differences of tuberculosis incidence in the US-born population aged 50 years or older in the United States. Clin Infect Dis. 2022;74(9):1594-1603. doi:10.1093/cid/ciab668

Lee K, You S, Li Y, Chesson H, Gift TL, Berruti AA, Hsu K, Yaesoubi R, Salomon JA, Rönn M. Estimation of the lifetime quality-adjusted life years (QALYs) lost due to syphilis acquired in the United States in 2018. Clin Infect Dis. 2022;ciac427. doi:10.1093/cid/ciac427

Li Y, Rönn M, Tuite A, Chesson H, Gift TL, Trikalinos T, Testa C, Bellerose M, Hsu K, Berruti A, Malyuta Y, Menzies NA, Salomon JA. Estimated costs and quality-adjusted life-years lost due to N. gonorrhoeae infections acquired in 2015 in the United States: A modelling study of overall burden and disparities by age, race/ethnicity, and other factors. Lancet Reg Health Am. 2022;16:100364. doi:10.1016/j.lana.2022.100364

Menzies NA, Shrestha S, Parriott A, Marks SM, Hill AN, Dowdy DW, Shete PB, Cohen T, Salomon JA. The health and economic benefits of tests that predict future progression to tuberculosis disease. Epidemiology. 2022;33(1):75-83. doi:10.1097/EDE.0000000000001418

Toy M, Hutton D, Harris AM, Nelson N, Salomon JA, So S. Cost-effectiveness of one-time universal screening for chronic hepatitis B infection in adults in the United States. Clin Infect Dis. 2022;74(2):210-217. doi:10.1093/cid/ciab405

Yaesoubi R, Cohen T, Hsu K, Gift TL, St Cyr SB, Salomon JA, Grad YH. Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics. PLoS Comput Biol. 2022;18(2):e1009842. doi:10.1371/journal.pcbi.1009842

Zhong H, Brandeau ML, Yazdi GE, Wang J, Nolen S, Hagan L, Thompson W, Assoumou S, Linas BP, Salomon JA. Metamodeling for policy simulations with multivariate outcomes. Med Decis Making. 2022;42(7):872-884. doi:10.1177/0272989X221105079


Bellerose M, Zhu L, Hagan LM, Thompson WW, Randall LM, Malyuta Y, Salomon JA, Linas BP. A review of network simulation models of hepatitis C virus and HIV among people who inject drugs. Int J Drug Policy. 2021;88:102580. doi:10.1016/j.drugpo.2019.10.006

Earnest R, Rönn MM, Bellerose M, Menon-Johansson AS, Berruti AA, Chesson HW, Gift TL, Hsu KK, Testa C, Zhu L, Malyuta Y, Menzies NA, Salomon JA. Modeling the cost-effectiveness of express multi-site gonorrhea screening among men who have sex with men in the United States. Sex Transm Dis. 2021;48(11):805-812. doi:10.1097/OLQ.0000000000001467

Menzies NA, Swartwood N, Testa C, Malyuta Y, Hill AN, Marks SM, Cohen T, Salomon JA. Time since infection and risks of future disease for individuals with mycobacterium tuberculosis infection in the United States. Epidemiology. 2021;32(1):70-78. doi:10.1097/EDE.0000000000001271


Assoumou SA, Nolen S, Hagan L, Wang J, Eftekhari Yazdi G, Thompson WW, Mayer KH, Puro J, Zhu L, Salomon JA, Linas BP. Hepatitis C management at federally qualified health centers during the opioid epidemic: A cost-effectiveness study. Am J Med. 2020;133(11):e641-e658. doi:10.1016/j.amjmed.2020.05.029

Assoumou SA, Tasillo A, Vellozzi C, Eftekhari Yazdi G, Wang J, Nolen S, Hagan L, Thompson W, Randall LM, Strick L, Salomon JA, Linas BP. Cost-effectiveness and budgetary impact of hepatitis C virus testing, treatment, and linkage to care in US prisons. Clin Infect Dis. 2020;70(7):1388-1396. doi:10.1093/cid/ciz383

Assoumou SA, Wang J, Nolen S, Eftekhari Yazdi G, Mayer KH, Puro J, Salomon JA, Linas BP. HCV testing and treatment in a national sample of US federally qualified health centers during the opioid epidemic. J Gen Intern Med. 2020;35(5):1477-1483. doi:10.1007/s11606-020-05701-9

Earnest R, Rönn MM, Bellerose M, Gift TL, Berruti AA, Hsu KK, Testa C, Zhu L, Malyuta Y, Menzies NA, Salomon JA. Population-level benefits of extragenital gonorrhea screening among men who have sex with men: An exploratory modeling analysis. Sex Transm Dis. 2020;47(7):484-490. doi:10.1097/OLQ.0000000000001189

Hill AN, Cohen T, Salomon JA, Menzies NA. High-resolution estimates of tuberculosis incidence among non-U.S.-born persons residing in the United States, 2000-2016. Epidemics. 2020;33:100419. doi:10.1016/j.epidem.2020.100419

Marks SM, Dowdy DW, Menzies NA, Shete PB, Salomon JA, Parriott A, Shrestha S, Flood J, Hill AN. Policy implications of mathematical modeling of latent tuberculosis infection testing and treatment strategies to accelerate tuberculosis eliminationPub Health Rep. 2020;135(1_suppl):38S-43S. doi:10.1177/0033354920912710

Menzies NA, Bellerose M, Testa C, Swartwood N, Malyuta Y, Cohen T, Marks SM, Hill AN, Date AA, Maloney SA, Bowden SE, Grills AW, Salomon JA. Impact of effective global tuberculosis control on health and economic outcomes in the United States. Am J Respir Crit Care Med. 2020;202(11):1567-1575. doi:10.1164/rccm.202003-0526OC

Menzies NA, Parriott A, Shrestha S, Dowdy DW, Cohen T, Salomon JA, Marks SM, Hill AN, Winston CA, Asay GR, Barry P, Readhead A, Flood J, Kahn JG, Shete PB. Comparative modeling of tuberculosis epidemiology and policy outcomes in California. Am J Respir Crit Care Med. 2020;201(3):356-365. doi:10.1164/rccm.201907-1289OC

Rönn MM, Dunville R, Wang LY, Bellerose M, Malyuta Y, Menzies NA, Aslam M, Lewis F, Walker-Baban C, Asbel L, Parchem S, Masinter L, Perez E, Gift TL, Hsu K, Barrios LC, Salomon JA. Mathematical modeling study of school-based chlamydia screening: potential impact on chlamydia prevalence in intervention schools and surrounding communities.BMC Public Health. 2020;20(1):1363. doi:10.1186/s12889-020-09466-y

Rönn MM, Menzies NA, Gift TL, Chesson HW, Trikalinos TA, Bellerose M, Malyuta Y, Berruti A, Gaydos CA, Hsu KK, Salomon JA. Potential for point-of-care tests to reduce chlamydia-associated burden in the United States: A mathematical modeling analysis. Clin Infect Dis. 2020;70(9):1816-1823. doi:10.1093/cid/ciz519

Rönn MM, Testa C, Tuite AR, Chesson HW, Gift TL, Schumacher C, Williford SL, Zhu L, Bellerose M, Earnest R, Malyuta Y, Hsu KK, Salomon JA, Menzies NA. The potential population-level impact of different gonorrhea screening strategies in Baltimore and San Francisco: An exploratory mathematical modeling analysis. Sex Transm Dis. 2020;47(3):143-150. doi:10.1097/OLQ.0000000000001108

Shrestha S, Parriott A, Menzies NA, Shete PB, Hill AN, Marks SM, Dowdy DW. Estimated population-level impact of using a six-week regimen of daily Rifapentine to treat latent tuberculosis infection in the United States. Ann Am Thorac Soc. 2020;17(12):1639-1642. doi:10.1513/AnnalsATS.202005-574RL

Tuite AR, Testa C, Rönn M, Bellerose M, Gift T, Fridge J, Molotnikov L, Desmarais C, Berruti A, Menzies N, Malyuta Y, Hsu K, Salomon JA. Exploring how epidemic context influences syphilis screening impact: A mathematical modeling study. Sex Transm Dis. 2020;47(12):798-810. doi:10.1097/OLQ.0000000000001249

Yaesoubi R, Cohen T, Hsu K, Gift TL, Chesson H, Salomon JA, Grad YH. Adaptive guidelines for the treatment of gonorrhea to increase the effective life span of antibiotics among men who have sex with men in the United States: A mathematical modeling study. PLoS Med. 2020;17(4):e1003077. doi:10.1371/journal.pmed.1003077

Zhu L, Menzies NA, Wang J, Linas BP, Goodreau SM, Salomon JA. Estimation and correction of bias in network simulations based on respondent-driven sampling data. Sci Rep. 2020;10(1):6348. doi:10.1038/s41598-020-63269-0


Assoumou SA, Wang J, Tasillo A, Eftekhari Yazdi G, Tsui JI, Strick L, Linas BP. Hepatitis C testing and patient characteristics in Washington state’s prisons between 2012 and 2016. Am J Prev Med. 2019;56(1):8-16. doi:10.1016/j.amepre.2018.08.016

Epstein RL, Wang J, Hagan L, Mayer KH, Puro J, Linas BP, Assoumou SA. Hepatitis C virus antibody testing among 13- to 21-year-olds in a large sample of US federally qualified health centers. JAMA. 2019;322(22):2245-2248. doi:10.1001/jama.2019.16196

Rönn MM, Tuite AR, Menzies NA, Wolf EE, Gift TL, Chesson HW, Torrone E, Berruti A, Mazzola A, Galer K, Hsu K, Salomon JA. The impact of screening and partner notification on chlamydia prevalence and numbers of infections averted in the United States, 2000–2015: Evaluation of epidemiologic trends using a pair-formation transmission model. Am J Epidemiol. 2019;188(3):545-554. doi:10.1093/aje/kwy272

Tasillo A, Eftekhari Yazdi G, Nolen S, Schillie S, Vellozzi C, Epstein R, Randall L, Salomon JA, Linas BP. Short-term effects and long-term cost-effectiveness of universal hepatitis C testing in prenatal care. Obstet Gynecol. 2019;133(2):289-300. doi:10.1097/AOG.0000000000003062


Barocas JA, Tasillo A, Eftekhari Yazdi G, Wang J, Vellozzi C, Hariri S, Isenhour C, Randall L, Ward JW, Mermin J, Salomon JA, Linas BP. Population level outcomes and cost-effectiveness of expanding the recommendation for age-based hepatitis C testing in the United States. Clin Infect Dis. 2018;67(4):549-556. doi:10.1093/cid/ciy098

Epstein RL, Sabharwal V, Wachman EM, Saia KA, Vellozzi C, Hariri S, Linas BP. Perinatal transmission of hepatitis C virus: Defining the cascade of care. J Pediatr. 2018;203:34-40.e1. doi:10.1016/j.jpeds.2018.07.006

Epstein RL, Wang J, Mayer K, Puro J, Horsburgh CR, Linas B, Assoumou SA. HCV screening practices among adolescents and young adults in a national sample of federally qualified health centers in the United States. Open Forum Infect Dis. 2018;5(Suppl 1):S74. doi:10.1093/ofid/ofy209.178

Menzies NA, Cohen T, Hill AN, Yaesoubi R, Galer K, Wolf E, Marks SM, Salomon JA. Prospects for tuberculosis elimination in the United States: Results of a transmission dynamic model. Am J Epidemiol. 2018;187(9):2011-2020. doi:10.1093/aje/kwy094

Menzies NA, Cohen T, Salomon JA. Evidence sources on the natural history of latent tuberculosis infection. Lancet Infect Dis. 2018;18(8):834-835. doi:10.1016/S1473-3099(18)30406-7

Menzies NA, Hill AN, Cohen T, Salomon JA. The impact of migration on tuberculosis in the United States. Int J Tuberc Lung Dis. 2018;22(12):1392-1403. doi:10.5588/ijtld.17.0185

Menzies NA, Wolf E, Connors D, Bellerose M, Sbarra AN, Cohen T, Hill AN, Yaesoubi R, Galer K, White PJ, Abubakar I, Salomon JA. Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions. Lancet Infect Dis. 2018;18(8):e228-e238. doi:10.1016/S1473-3099(18)30134-8

Tuite AR, Rönn MM, Wolf EE, Gift TL, Chesson HW, Berruti A, Galer K, Menzies NA, Hsu K, Salomon JA. Estimated impact of screening on gonorrhea epidemiology in the United States: Insights from a mathematical model. Sex Transm Dis. 2018;45(11):713-722. doi:10.1097/OLQ.0000000000000876


Barocas JA, Wang J, White LF, Tasillo A, Salomon JA, Freedberg KA, Linas BP. Hepatitis C testing increased among baby boomers following the 2012 change to CDC testing recommendations. Health Aff (Millwood). 2017;36(12):2142-2150. doi:10.1377/hlthaff.2017.0684

Neilan A, Dunville R, Ocfemia MC, Salomon J, Francke J, Wang LY, Bulteel A, Hsu K, DiNenno E, Parker R, Walensky R. Screening adolescents and young adults for HIV in the United States: A cost-effectiveness analysis. J Adolesc Health. 2017;60(2):S18. doi:10.1016/j.jadohealth.2016.10.055

Rönn MM, Wolf E, Chesson HW, Menzies NA, Galer K, Gorwitz R, Gift TL, Hsu K, Salomon JA. The use of mathematical models of chlamydia transmission to address public health policy questions: A systematic literature review. Sex Transm Dis. 2017;44(5):278-283. doi:10.1097/OLQ.0000000000000598

Tasillo A, Salomon JA, Trikalinos TA, Horsburgh CR, Marks SM, Linas BP. Cost-effectiveness of testing and treatment for latent tuberculosis infection in residents born outside the United States with and without medical comorbidities in a simulation model. JAMA Intern Med. 2017;177(12):1755-1764. doi:10.1001/jamainternmed.2017.3941

Tuite AR, Gift TL, Chesson HW, Hsu K, Salomon JA, Grad YH. Impact of rapid susceptibility testing and antibiotic selection strategy on the emergence and spread of antibiotic resistance in gonorrhea. J Infect Dis. 2017;216(9):1141-1149. doi:10.1093/infdis/jix450